Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SciSparc Ltd.SPRC · Entity 8412 | Director | March 18, 2026 | July 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SciSparc Ltd.
Report date March 18, 2026 · Filed July 13, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 11,058 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 11,058 F1: This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends and restates the first footnote in Table I as follows: "Includes (i) 10,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 1,250 Ordinary Shares through December 18, 2027; and (ii) 1,058 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 132 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share." |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31,941.00 · Expires 2028-01-03 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance Not disclosed F2: This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form is filed solely as an amendment to the Form 3 filed on March 18, 2026. This amendment amends and restates the first footnote in Table I as follows: "Includes (i) 10,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") in quarterly installments of 1,250 Ordinary Shares through December 18, 2027; and (ii) 1,058 Ordinary Shares issuable upon the vesting of RSUs in equal quarterly installments of 132 Ordinary Shares through June 20, 2026. Each RSU represents the right to receive one Ordinary Share."
F2: This amendment amends and restates Table II of the initial Form 3, as provided herein. No amendment is made hereby to any other footnotes of the initial Form 3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 12:00 UTC | SciSparc Ltd. SPRC · Entity 8412 | SaleOrdinary Shares | 462 | $10.00 | $4,620.00 |
DisclosureSEC source: 0001213900-26-064445 · ownership.xml · nonDerivative · entry 1 Shrem Itschak · CIK 0001595943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,596 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.